TrialFrontiers in immunology2021

Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation.

Hatice Hasturk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.